Abstract: In an aspect a system for electric charger communication is presented. A system includes a first networking component and sensor of a first electric charger. The system includes at least a processor communicatively connected to a first networking component and the sensor. The system includes memory communicatively connected to at least a processor, wherein the memory contains instructions configuring at least a processor to receive the at least a charger metric from the sensor and transmit the at least a charger metric to the network using the first communicative connection, wherein the at least a charger metric comprises a charger status.

Abstract: A method of joining an interior wall and a composite channel together is disclosed. The method includes wrapping one or more first composite plies around a first end portion of a first mandrel and wrapping one or more second composite plies around a second end portion of a second mandrel. The method includes positioning the one or more first composite plies located on the first end portion of the first mandrel against the one or more second composite plies located on the second end portion of the second mandrel to create the interior wall, and inserting the first mandrel and the second mandrel into a passageway of a composite channel. The interior wall created by the one or more first composite plies and the one or more second composite plies creates a barrier to block a flow of fluid within the passageway of the composite channel.

Abstract: Systems and methods are provided for utilizing stringer end caps. One embodiment is a method of forming a stringer. The method includes laying up a stringer preform comprising fiber-reinforced material, placing the stringer preform onto a skin panel preform, bonding an end cap to the stringer preform and the skin panel preform, and co-curing the stringer preform and the skin panel preform while the end cap is bonded to the stringer preform and the skin panel preform, resulting in a composite part that includes the end cap.

Abstract: A method includes dispensing a first set of lanes, that each comprise a tow of fiber-reinforced material, at a first angle such that the lanes are placed side-by-side with respect to each other, forming a first layer of a multi-lane tow. The method further includes applying a film directly in contact with multi-lane tow that resists shear forces applied to the multi-lane tow, transporting the multi-lane tow to a mandrel, and compacting the multi-lane tow via a Ply-By-Ply (PBP) machine disposed at the mandrel. The method further comprises removing the film from the multi-lane tow.

Abstract: Systems and methods are provided for fabricating composite parts. One embodiment is a method for fabricating a composite part. The method includes forming a skin panel preform comprising fiber reinforced material, disposing rigid end caps at the skin panel preform at end locations of stringer preforms that will be placed at the skin panel, locating the stringer preforms at the skin panel preform via the rigid end caps, and anchoring the stringer preforms to the skin panel preform.

Abstract: A method includes dispensing a first set of lanes, that each comprise a tow of fiber-reinforced material, at a first angle such that the lanes are placed side-by-side with respect to each other, forming a first layer of a multi-lane tow. The method further includes applying a film directly in contact with multi-lane tow that resists shear forces applied to the multi-lane tow, transporting the multi-lane tow to a mandrel, and compacting the multi-lane tow via a Ply-By-Ply (PBP) machine disposed at the mandrel. The method further comprises removing the film from the multi-lane tow.

Abstract: Systems and methods are provided for fabricating composite parts. One embodiment is a method for fabricating a composite part. The method includes forming a skin panel preform comprising fiber reinforced material, disposing rigid end caps at the skin panel preform at end locations of stringer preforms that will be placed at the skin panel, locating the stringer preforms at the skin panel preform via the rigid end caps, and anchoring the stringer preforms to the skin panel preform.

Abstract: Systems and methods are provided for utilizing stringer end caps. One embodiment is a method of forming a stringer. The method includes laying up a stringer preform comprising fiber-reinforced material, placing the stringer preform onto a skin panel preform, bonding an end cap to the stringer preform and the skin panel preform, and co-curing the stringer preform and the skin panel preform while the end cap is bonded to the stringer preform and the skin panel preform, resulting in a composite part that includes the end cap.

Abstract: A method of joining an interior wall and a composite channel together is disclosed. The method includes wrapping one or more first composite plies around a first end portion of a first mandrel and wrapping one or more second composite plies around a second end portion of a second mandrel. The method includes positioning the one or more first composite plies located on the first end portion of the first mandrel against the one or more second composite plies located on the second end portion of the second mandrel to create the interior wall, and inserting the first mandrel and the second mandrel into a passageway of a composite channel. The interior wall created by the one or more first composite plies and the one or more second composite plies creates a barrier to block a flow of fluid within the passageway of the composite channel.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: Aqueous liquid having an oxygen demand flows into a treatment vessel where it is treated by suspended aerobic bacterial solids in the presence of dissolved oxygen. A pressurised flow of the treated liquid passes to a clarifying membrane separator effective to separate the flow into a discharge stream of clear liquid and a pressurised recycle stream concentrated in the aerobic bacterial solids. A first oxic gas is employed to scour the membranes and is conveyed away from the membrane separator in the pressurised recycle stream. The pressurised recycle stream is returned to under the surface of the liquid in the treatment vessel. A second oxic gas is introduced either into the pressurised recycle stream or into a further pressurised stream of aqueous liquid flowing into the same volume. The rate of introduction of the oxic gases is controlled with reference to the pH and dissolved oxygen concentration of the liquid in the vessel.

Abstract: A process for managing contingent labor costs includes, following occurrence of a predetermined event indicative of a point at which a staffing firm has earned a threshold revenue from a contingent worker recruited by the staffing firm, causing the contingent worker to become an employee of a maintenance firm; providing a labor consumer with services generated by said employee; and receiving revenue from said labor consumer for said services

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucleotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: In accordance with the present invention, there are provided fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). Nucelotide sequences encoding and amino acid sequences comprising heavy and light chain immunoglobulin molecules, particularly contiguous heavy and light chain sequences spanning the complementarity determining regions (CDRs), specifically from within FR1 and/or CDR1 through CDR3 and/or within FR4, are provided. Further provided are antibodies having similar binding properties and antibodies (or other antagonists) having similar functionality as antibodies disclosed herein.

Abstract: Aqueous liquid having an oxygen demand flows into a treatment vessel where it is treated by suspended aerobic bacterial solids in the presence of dissolved oxygen. A pressurised flow of the treated liquid passes to a clarifying membrane separator effective to separate the flow into a discharge stream of clear liquid and a pressurised recycle stream concentrated in the aerobic bacterial solids. A first oxic gas is employed to scour the membranes and is conveyed away from the membrane separator in the pressurised recycle stream. The pressurised recycle stream is returned to under the surface of the liquid in the treatment vessel. A second oxic gas is introduced either into the pressurised recycle stream or into a further pressurised stream of aqueous liquid flowing into the same volume. The rate of introduction of the oxic gases is controlled with reference to the pH and dissolved oxygen concentration of the liquid in the vessel.